| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Carisma Therapeutics Inc.
13D/A
CARM · 14216R101
|
0% |
9/2/2025
Event 9/2/2025
|
||||
| HealthCap VII, L.P. | 0% | |||||
| HealthCap VII GP LLC | 0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.